查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1963924

医疗保健第三方物流市场－全球产业规模、份额、趋势、机会与预测：按产业、服务类型、供应链、地区和竞争对手划分，2021-2031年

Healthcare Third party Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Industry, By Service Type, By Supply Chain, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球医疗保健第三方物流市场预计将从 2025 年的 2.6634 亿美元成长到 2031 年的 4.0693 亿美元，复合年增长率达到 7.32%。

该市场指的是将运输、仓储和库存管理等供应链管理职能策略性外包给专业的外部供应商，其主要驱动因素是医药贸易的全球化、对温度生物製药分销日益复杂化，以及製造商需要透过外部专业知识来优化营运成本。

市场概览
预测期 2027-2031
市场规模：2025年 2.6634亿美元
市场规模：2031年 4.0693亿美元
复合年增长率：2026-2031年 7.32%
成长最快的细分市场 製药
最大的市场 北美洲

根据欧洲製药工业协会联合会（EFPIA）的估计值，到2024年，北美将占全球药品销售额的54.8%。如此庞大的规模表明，需要建立强大的物流网络来处理跨区域的医疗产品分销。然而，由于监管环境复杂且分散，该市场面临巨大的挑战。不同司法管辖区的合规标准各不相同，提出了严格的要求，这不仅增加了物流供应商的营运复杂性，也增加了其责任风险。

市场驱动因素

生物製药、疫苗和细胞疗法的快速增长推动了对温控低温运输物流需求的激增，这些产品需要严格的热稳定性以防止变质，从而从根本上改变了全球医疗保健第三方物流市场。正如马士基在2024年4月发布的报告预测，当年全球生物製药低温运输物流支出预计将达到213亿美元，而蓬勃发展的国际贸易网络也支撑了这一趋势。国际航空运输协会（IATA）指出，2024年全球航空货运需求增加了11.3%，凸显了对医疗保健供应链至关重要的国际运输量的显着增长。

第二个主要驱动因素是外包非核心物流业务的趋势日益增长。这使得製药公司能够专注于研发，同时透过将复杂的供应链营运委託给外部专家，降低成本并避免维护内部基础设施。物流供应商正积极扩大产能以满足此需求。例如，DHL供应链于2024年2月宣布投资2亿美元，用于扩展其在美国生命科学和医疗保健领域的基础设施，旨在满足该领域日益增长的需求，特别是对专业仓储和配送解决方案的需求。

市场挑战

复杂且分散的监管环境对全球医疗保健第三方物流市场的扩张构成重大障碍。供应商必须应对错综复杂的合规标准，包括良好分销规范 (GDP) 和序列化要求，而这些要求因地区而异。这种不协调迫使企业维持专门的品质保证团队和冗余的合规系统，导致营运成本增加、责任风险加大，以及将关键资源从基础设施建设和市场扩张中转移出去。

这些严格要求带来的经济影响体现在产业盈利的下降，从而限制了可用于成长的资金。 2024年，医疗保健分销商联盟（HDA）报告称，药品经销商的净利率降至仅0.2%。获利能力的下降是由于遵守严格的营运和合规标准所带来的高成本，这严重限制了物流供应商投资必要技术升级或进入新的复杂市场的财务能力。

市场趋势

将人工智慧驱动的预测分析应用于需求预测，正在改变市场格局，使供应商能够考虑天气和地缘政治事件等风险，预测中断情况，并即时优化路线。这种向主动式供应链管理的转变对于高价值药品至关重要。正如《供应链管理执行官》2025年11月刊所指出的，53%的药品价值链领导者目前正在投资人工智慧和机器学习，尤其用于产生预测性风险警报和增强营运韧性。

同时，在製药企业努力透过使用电动车和永续航空燃料（SAF）来减少范围3排放的背景下，采用永续和环保的物流措施正成为供应商选择的关键因素。这种转型是满足客户永续性要求和全球法规的策略性需求。例如，根据《碳信用》（Carbon Credits）2025年12月的一篇报导，DHL Express已签署一份具有约束力的合同，采购5000万升SAF以支持其航空货运业务，直接满足了行业对低碳运输解决方案日益增长的需求。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球医疗保健第三方物流市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依行业（生物製药、医疗设备、药品）
    • 服务类型（运输、仓储、其他）
    • 按类型分類的供应链（低温运输、非低温运输）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美医疗保健第三方物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲医疗保健第三方物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区医疗保健第三方物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲医疗保健第三方物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美医疗保健第三方物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球医疗保健第三方物流市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Cardinal Health
  • DHL Group
  • SF Express
  • Kinesis Medical BV
  • United Parcel Service of America, Inc.
  • Barrett Distribution
  • AmerisourceBergen Corporation
  • KUEHNE+NAGEL
  • Kerry Logistics Network Ltd.
  • Freight Logistics Solutions

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20736

The Global Healthcare Third-party Logistics Market is projected to expand from USD 266.34 Million in 2025 to USD 406.93 Million by 2031, achieving a compound annual growth rate of 7.32%. Defined as the strategic outsourcing of supply chain management functions-such as transportation, warehousing, and inventory control-to specialized external providers, the market is primarily driven by the globalization of pharmaceutical trade, the growing complexity of distributing temperature-sensitive biologics, and the necessity for manufacturers to optimize operational costs through external expertise.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 266.34 Million
Market Size 2031USD 406.93 Million
CAGR 2026-20317.32%
Fastest Growing SegmentPharmaceutical
Largest MarketNorth America

According to the European Federation of Pharmaceutical Industries and Associations, North America represented 54.8% of estimated global pharmaceutical sales in 2024, a volume that underscores the critical need for robust logistical networks to handle medical product flows across diverse regions. However, the market faces significant challenges due to an intricate and fragmented regulatory landscape; varying compliance standards across different jurisdictions enforce rigorous requirements that increase both operational complexity and liability risks for logistics providers.

Market Driver

A surging demand for temperature-controlled cold chain logistics is fundamentally reshaping the Global Healthcare Third-party Logistics Market, necessitated by the rapid growth of biologics, vaccines, and cell therapies that require strict thermal stability to avoid spoilage. As reported by Maersk in April 2024, global expenditure on biopharma cold chain logistics was projected to reach $21.3 billion that year, a trend supported by the vitality of global trade networks; the International Air Transport Association noted that global air cargo demand rose by 11.3% in 2024, highlighting the substantial volume of international shipments crucial for healthcare supply chains.

A second primary driver is the increasing trend of outsourcing non-core logistics operations, which allows pharmaceutical companies to focus on research and development while delegating complex supply chain tasks to external experts to save costs and avoid maintaining in-house infrastructure. Logistics providers are aggressively scaling their capabilities to meet this demand; for instance, DHL Supply Chain announced a $200 million investment in February 2024 to expand its life sciences and healthcare infrastructure in the United States, specifically aiming to accommodate the sector's rising need for specialized warehousing and distribution solutions.

Market Challenge

The intricate and fragmented regulatory landscape poses a formidable barrier to the expansion of the Global Healthcare Third-party Logistics Market, as providers must navigate a complex web of compliance standards like Good Distribution Practices (GDP) and serialization mandates that differ significantly by jurisdiction. This lack of harmonization forces companies to maintain specialized quality assurance teams and redundant compliance systems, which drives up operational overhead, increases liability risks, and diverts critical resources away from infrastructure development and market expansion.

The economic consequences of these stringent requirements are reflected in the sector's diminishing profitability, which restricts the capital available for growth. In 2024, the Healthcare Distribution Alliance reported that net profit margins for pharmaceutical distributors dropped to just 0.2 percent; these constricted margins, resulting from the high costs of adhering to rigorous operational and compliance standards, severely limit the financial capacity of logistics providers to invest in necessary technology upgrades or enter new, complex markets.

Market Trends

The integration of AI-driven predictive analytics for demand forecasting is transforming the market by enabling providers to anticipate disruptions and optimize routes in real-time, accounting for risks such as weather or geopolitical events. This shift toward proactive supply chain management is essential for high-value pharmaceuticals, as highlighted by a November 2025 report in Supply & Demand Chain Executive, which noted that 53% of pharmaceutical supply chain leaders are currently evaluating AI and machine learning specifically to generate predictive risk alerts and enhance operational resilience.

Simultaneously, the implementation of sustainable and green logistics initiatives is becoming a decisive factor in vendor selection, driven by pharmaceutical manufacturers' commitments to reduce Scope 3 emissions through the use of electric vehicles and sustainable aviation fuels (SAF). This transition is a strategic imperative to meet client sustainability mandates and global regulations; for example, a December 2025 Carbon Credits article reported that DHL Express secured a binding contract for 50 million liters of SAF to support its air cargo operations, directly addressing the sector's growing demand for low-carbon transport solutions.

Key Market Players

  • Cardinal Health
  • DHL Group
  • SF Express
  • Kinesis Medical B.V.
  • United Parcel Service of America, Inc.
  • Barrett Distribution
  • AmerisourceBergen Corporation
  • KUEHNE + NAGEL
  • Kerry Logistics Network Ltd.
  • Freight Logistics Solutions

Report Scope

In this report, the Global Healthcare Third party Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Healthcare Third party Logistics Market, By Industry

  • Biopharmaceutical
  • Medical Device
  • Pharmaceutical

Healthcare Third party Logistics Market, By Service Type

  • Transportation
  • Warehousing and Storage
  • Others

Healthcare Third party Logistics Market, By Supply Chain

  • Cold Chain
  • Non-Cold Chain

Healthcare Third party Logistics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Third party Logistics Market.

Available Customizations:

Global Healthcare Third party Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Healthcare Third party Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Industry (Biopharmaceutical, Medical Device, Pharmaceutical)
    • 5.2.2. By Service Type (Transportation, Warehousing and Storage, Others)
    • 5.2.3. By Supply Chain (Cold Chain, Non-Cold Chain)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Healthcare Third party Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Industry
    • 6.2.2. By Service Type
    • 6.2.3. By Supply Chain
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Healthcare Third party Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Industry
        • 6.3.1.2.2. By Service Type
        • 6.3.1.2.3. By Supply Chain
    • 6.3.2. Canada Healthcare Third party Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Industry
        • 6.3.2.2.2. By Service Type
        • 6.3.2.2.3. By Supply Chain
    • 6.3.3. Mexico Healthcare Third party Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Industry
        • 6.3.3.2.2. By Service Type
        • 6.3.3.2.3. By Supply Chain

7. Europe Healthcare Third party Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Industry
    • 7.2.2. By Service Type
    • 7.2.3. By Supply Chain
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Healthcare Third party Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Industry
        • 7.3.1.2.2. By Service Type
        • 7.3.1.2.3. By Supply Chain
    • 7.3.2. France Healthcare Third party Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Industry
        • 7.3.2.2.2. By Service Type
        • 7.3.2.2.3. By Supply Chain
    • 7.3.3. United Kingdom Healthcare Third party Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Industry
        • 7.3.3.2.2. By Service Type
        • 7.3.3.2.3. By Supply Chain
    • 7.3.4. Italy Healthcare Third party Logistics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Industry
        • 7.3.4.2.2. By Service Type
        • 7.3.4.2.3. By Supply Chain
    • 7.3.5. Spain Healthcare Third party Logistics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Industry
        • 7.3.5.2.2. By Service Type
        • 7.3.5.2.3. By Supply Chain

8. Asia Pacific Healthcare Third party Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Industry
    • 8.2.2. By Service Type
    • 8.2.3. By Supply Chain
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Healthcare Third party Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Industry
        • 8.3.1.2.2. By Service Type
        • 8.3.1.2.3. By Supply Chain
    • 8.3.2. India Healthcare Third party Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Industry
        • 8.3.2.2.2. By Service Type
        • 8.3.2.2.3. By Supply Chain
    • 8.3.3. Japan Healthcare Third party Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Industry
        • 8.3.3.2.2. By Service Type
        • 8.3.3.2.3. By Supply Chain
    • 8.3.4. South Korea Healthcare Third party Logistics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Industry
        • 8.3.4.2.2. By Service Type
        • 8.3.4.2.3. By Supply Chain
    • 8.3.5. Australia Healthcare Third party Logistics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Industry
        • 8.3.5.2.2. By Service Type
        • 8.3.5.2.3. By Supply Chain

9. Middle East & Africa Healthcare Third party Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Industry
    • 9.2.2. By Service Type
    • 9.2.3. By Supply Chain
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Healthcare Third party Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Industry
        • 9.3.1.2.2. By Service Type
        • 9.3.1.2.3. By Supply Chain
    • 9.3.2. UAE Healthcare Third party Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Industry
        • 9.3.2.2.2. By Service Type
        • 9.3.2.2.3. By Supply Chain
    • 9.3.3. South Africa Healthcare Third party Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Industry
        • 9.3.3.2.2. By Service Type
        • 9.3.3.2.3. By Supply Chain

10. South America Healthcare Third party Logistics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Industry
    • 10.2.2. By Service Type
    • 10.2.3. By Supply Chain
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Healthcare Third party Logistics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Industry
        • 10.3.1.2.2. By Service Type
        • 10.3.1.2.3. By Supply Chain
    • 10.3.2. Colombia Healthcare Third party Logistics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Industry
        • 10.3.2.2.2. By Service Type
        • 10.3.2.2.3. By Supply Chain
    • 10.3.3. Argentina Healthcare Third party Logistics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Industry
        • 10.3.3.2.2. By Service Type
        • 10.3.3.2.3. By Supply Chain

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Healthcare Third party Logistics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cardinal Health
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DHL Group
  • 15.3. SF Express
  • 15.4. Kinesis Medical B.V.
  • 15.5. United Parcel Service of America, Inc.
  • 15.6. Barrett Distribution
  • 15.7. AmerisourceBergen Corporation
  • 15.8. KUEHNE + NAGEL
  • 15.9. Kerry Logistics Network Ltd.
  • 15.10. Freight Logistics Solutions

16. Strategic Recommendations

17. About Us & Disclaimer